A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb Spasticity

Written by ClinicalTrials.gov

Category: Muscle Diseases

Published: 17 June 2010

Conditions: Cerebrovascular Accident; Spasticity, Post-Stroke
Interventions: Drug: Botulinum toxin type A; Drug: placebo
Sponsor: GlaxoSmithKline
Completed - verified July 2011

Details: Last Updated: 17 June 2010

Find, Use, Share, Expand Orthopaedic Information

Improving orthopaedic care, education and research using Internet technologies